What are the major opportunities in the Lunsumio market? What are the strategies for the Lunsumio market?

For detailed insights on the major opportunities and strategies in the Lunsumio market, Read More

How does the Lunsumio market relate to the overall economy and other similar markets?

For detailed insights on Lunsumio's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Lunsumio market growth? SWOT analysis of the Lunsumio market.

For detailed insights on the key dynamics influencing the Lunsumio market growth and SWOT analysis of the Lunsumio industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Lunsumio Global Market Report 2025

Name: Lunsumio Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Formulation (Injectable Formulation (Intravenous), Pre-Filled Syringes), By Indication (Treatment Of Relapsed Or Refractory FL, Treatment Of Other Non-Hodgkin Lymphomas), By Patient Demographics (Adult Patients, Geriatric Patients, Patients With High-Risk Disease Profiles), By Distribution Channel (Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Oncology Clinics, Specialty Pharmacies, Research Institutions)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Lunsumio Market?

Lunsumio (mosunetuzumab) is a bispecific antibody to treat relapsed or refractory follicular lymphoma. It targets CD20 on B-cells and CD3 on T-cells, aiming to enhance immune system activity against cancer cells. It is approved for patients who have failed prior therapies, offering a novel approach to cancer immunotherapy.

The main formulations of lunsumio are injectable formulation (intravenous) and pre-filled syringes. Injectable formulations in the intravenous (IV) form are drugs prepared for direct administration into the bloodstream. IV formulations of lunsumio provide precise dosing and are used for patients who need immediate therapeutic effects. This type of formulation is preferred in clinical settings, particularly for patients with severe conditions. It is indicated for the treatment of relapsed or refractory follicular lymphoma (FL) and other non-Hodgkin lymphomas. It is distributed through direct sales, wholesalers, distributors, retail pharmacies, and online pharmacies, and is utilized by end users in Hospitals, oncology clinics, specialty pharmacies, and research institutions.

Lunsumio Market Size and growth rate 2025 to 2029: Graph

What Is The Lunsumio Market Size 2025 And Growth Rate?

The lunsumio market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing cancer prevalence, improved diagnosis and screening, enhanced patient awareness, higher healthcare spending, and growing demand for personalized medicine.

What Is The Lunsumio Market Growth Forecast?

The lunsumio market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising adoption of targeted therapies, growing oncology pipeline, increasing use of immunotherapies, expanding healthcare access, and regulatory support for cancer drugs. Major trends in the forecast period include the increasing focus on precision medicine, growth in biosimilar competition, increasing use of combination therapies, greater patient-centric approaches, and increasing partnership between biotech and pharma companies

Book your 30 minutes free consultation with our research experts

How Is The Lunsumio Market Segmented?

The lunsumio market covered in this report is segmented –

1) By Formulation: Injectable Formulation (Intravenous), Pre-Filled Syringes

2) By Indication: Treatment Of Relapsed Or Refractory FL, Treatment Of Other Non-Hodgkin Lymphomas

3) By Patient Demographics: Adult Patients, Geriatric Patients, Patients With High-Risk Disease Profiles

4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Oncology Clinics, Specialty Pharmacies, Research Institutions

What Is Driving The Lunsumio Market? Increasing Prevalence Of Blood Cancer Drives Growth In The Market

The increasing prevalence of blood cancer is expected to propel the growth of the lunsumio market going forward. Blood cancer refers to cancers that affect the production and function of blood cells, typically originating in the bone marrow or lymphatic system. The most common types include leukemia, lymphoma, and myeloma. The increasing prevalence of blood cancer can be attributed to factors such as an aging population, genetic predisposition, environmental exposures, weakened immune systems, lifestyle choices, and advancements in diagnostic techniques. Lunsumio (mosunetuzumab) is a bispecific antibody that helps treat blood cancers such as lymphoma by targeting and binding to both cancerous B cells and T cells, enabling the immune system to destroy the cancer cells. It is effective in managing diseases with high blood cancer prevalence, offering a treatment option for patients with relapsed or refractory conditions. For instance, in August 2022, according to Cancer Australia, an Australia-based government agency, in 2022, an estimated 5,202 new cases of leukemia were diagnosed in Australia, with 3,198 cases among males and 2,004 among females. Further, a person has a 1 in 58 (or 1.7%) chance of being diagnosed with leukemia by age 85. This risk is higher for males, at 1 in 47 (2.1%), compared to females, at 1 in 77 (1.3%). Therefore, the increasing prevalence of blood cancer is driving the growth of the lunsumio market.

Who Are The Major Players In The Global Lunsumio Market?

Major companies operating in the lunsumio market include Roche Holding AG

What Are The Key Trends Of The Global Lunsumio Market? FDA Approval Of Lunsumio For Relapsed Or Refractory Follicular Lymphoma Boosts Market Outlook

The key trend in the lunsumio market is innovative therapies such as bispecific antibodies to enhance treatment efficacy and target specific cancer cells more effectively. Bispecific antibody therapies refer to engineered antibodies that can bind to two targets simultaneously, improving treatment efficacy by addressing multiple disease mechanisms. For instance, in December 2022, Roche Holding AG, a Switzerland-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for lunsumio as a treatment for adult patients with relapsed or refractory follicular lymphoma after at least two prior therapies. The FDA approval is based on positive results from the Phase II GO29781 study of lunsumio in people with heavily pretreated FL, including those at high risk of disease progression or whose disease was refractory to prior therapies.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Lunsumio Market? Lonza Group Ag Acquires Genentech Manufacturing Facility From Roche To Expand Biopharmaceutical Production Capacity

In October 2024, Lonza Group AG, a Switzerland-based manufacturing company that supplies pharmaceutical, healthcare, and life science products, acquired the Genentech manufacturing facility from Roche for $1.2 billion. With this acquisition, Lonza Group AG aims to expand its production capacity, enhance its technological capabilities, and strengthen its position as a leading provider of contract development and manufacturing services for the biopharmaceutical industry. Roche Holding AG is a Switzerland-based pharmaceutical company that developed Lunsumio (mosunetuzumab) to treat relapsed or refractory follicular lymphoma.

Regional Analysis For The Global Lunsumio Market

North America was the largest region in the lunsumio market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lunsumio market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lunsumio market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Lunsumio Market?

The lunsumio market consists of sales of lunsumio (mosunetuzumab) 30 mg/30m, and lunsumio (mosunetuzumab -axgb) 1mh/ml. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Lunsumio Industry?

The lunsumio market research report is one of a series of new reports from The Business Research Company that provides lunsumio market statistics, including the lunsumio industry's global market size, regional shares, competitors with a lunsumio market share, detailed lunsumio market segments, market trends and opportunities, and any further data you may need to thrive in the lunsumio industry. This lunsumio market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Lunsumio Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Formulation: Injectable Formulation (Intravenous), Pre-Filled Syringes 2) By Indication: Treatment Of Relapsed Or Refractory FL, Treatment Of Other Non-Hodgkin Lymphomas 3) By Patient Demographics: Adult Patients, Geriatric Patients, Patients With High-Risk Disease Profiles 4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies 5) By End User: Hospitals, Oncology Clinics, Specialty Pharmacies, Research Institutions
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Roche Holding AG
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Lunsumio Market Characteristics

3. Lunsumio Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Lunsumio Market Trends And Strategies

5. Lunsumio Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Lunsumio Growth Analysis And Strategic Analysis Framework

6.1. Global Lunsumio PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Lunsumio Market Growth Rate Analysis

6.4. Global Lunsumio Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Lunsumio Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Lunsumio Total Addressable Market (TAM)

7. Global Lunsumio Pricing Analysis & Forecasts

8. Lunsumio Market Segmentation

8.1. Global Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Injectable Formulation (Intravenous)

Pre-Filled Syringes

8.2. Global Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Treatment Of Relapsed Or Refractory FL

Treatment Of Other Non-Hodgkin Lymphomas

8.3. Global Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adult Patients

Geriatric Patients

Patients With High-Risk Disease Profiles

8.4. Global Lunsumio Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Direct Sales

Wholesalers And Distributors

Retail Pharmacies

Online Pharmacies

8.5. Global Lunsumio Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Oncology Clinics

Specialty Pharmacies

Research Institutions

9. Global Lunsumio Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Lunsumio Market Regional And Country Analysis

10.1. Global Lunsumio Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Lunsumio Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Lunsumio Market

11.1. Asia-Pacific Lunsumio Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Lunsumio Market

12.1. China Lunsumio Market Overview

12.2. China Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Lunsumio Market

13.1. India Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Lunsumio Market

14.1. Japan Lunsumio Market Overview

14.2. Japan Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Lunsumio Market

15.1. Australia Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Lunsumio Market

16.1. South Korea Lunsumio Market Overview

16.2. South Korea Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Lunsumio Market

17.1. Western Europe Lunsumio Market Overview

17.2. Western Europe Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Lunsumio Market

18.1. UK Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Lunsumio Market

19.1. Germany Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Lunsumio Market

20.1. France Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Lunsumio Market

21.1. Eastern Europe Lunsumio Market Overview

21.2. Eastern Europe Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Lunsumio Market

22.1. North America Lunsumio Market Overview

22.2. North America Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Lunsumio Market

23.1. USA Lunsumio Market Overview

23.2. USA Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Lunsumio Market

24.1. Canada Lunsumio Market Overview

24.2. Canada Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Lunsumio Market

25.1. South America Lunsumio Market Overview

25.2. South America Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Lunsumio Market

26.1. Middle East Lunsumio Market Overview

26.2. Middle East Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Lunsumio Market

27.1. Africa Lunsumio Market Overview

27.2. Africa Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Lunsumio Market Competitive Landscape And Company Profiles

28.1. Lunsumio Market Competitive Landscape

28.2. Lunsumio Market Company Profiles

28.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

29. Global Lunsumio Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Lunsumio Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Lunsumio Market

32. Recent Developments In The Lunsumio Market

33. Lunsumio Market High Potential Countries, Segments and Strategies

33.1 Lunsumio Market In 2029 - Countries Offering Most New Opportunities

33.2 Lunsumio Market In 2029 - Segments Offering Most New Opportunities

33.3 Lunsumio Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Lunsumio Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Lunsumio Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Lunsumio Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Global Lunsumio Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: Asia-Pacific, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: China, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: India, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Japan, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: Australia, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: South Korea, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: Western Europe, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: UK, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: Germany, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: France, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: Eastern Europe, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: North America, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: USA, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: Canada, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: South America, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Middle East, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: Africa, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 61: Roche Holding AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Lunsumio Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Lunsumio Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Lunsumio Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Global Lunsumio Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: Asia-Pacific, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: China, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: India, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Japan, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: Australia, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: South Korea, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: Western Europe, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: UK, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: Germany, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: France, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: Eastern Europe, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: North America, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: USA, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: Canada, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: South America, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Middle East, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Lunsumio Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Lunsumio Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: Africa, Lunsumio Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 61: Roche Holding AG Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Hematology Drugs Global Market Report 2022 – By Type (Blood Products, Anemia And Other Blood Disorder Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administrat...

Metabolic Disorders Drugs Global Market Report 2022 – By Type (Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)), By Distribution Channel (Hospital Pharmacies, Retai...

Frequently Asked Questions

What is the definition of the Lunsumio market?

How will the Lunsumio market drivers and restraints affect the market dynamics? What forces will shape the Lunsumio industry going forward?

The Lunsumio market major growth driver - Increasing Prevalence Of Blood Cancer Drives Growth In The Market. For further insights on the Lunsumio market, request a sample here

What is the forecast market size or the forecast market value of the Lunsumio market?

The Lunsumio market size has grown strongly in recent years. The lunsumio market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing cancer prevalence, improved diagnosis and screening, enhanced patient awareness, higher healthcare spending, and growing demand for personalized medicine. The lunsumio market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising adoption of targeted therapies, growing oncology pipeline, increasing use of immunotherapies, expanding healthcare access, and regulatory support for cancer drugs. Major trends in the forecast period include the increasing focus on precision medicine, growth in biosimilar competition, increasing use of combination therapies, greater patient-centric approaches, and increasing partnership between biotech and pharma companies For further insights on the Lunsumio market, request a sample here

How is the Lunsumio market segmented?

The lunsumio market covered in this report is segmented –
1) By Formulation: Injectable Formulation (Intravenous), Pre-Filled Syringes
2) By Indication: Treatment Of Relapsed Or Refractory FL, Treatment Of Other Non-Hodgkin Lymphomas
3) By Patient Demographics: Adult Patients, Geriatric Patients, Patients With High-Risk Disease Profiles
4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Oncology Clinics, Specialty Pharmacies, Research Institutions For further insights on the Lunsumio market, request a sample here

Which region has the largest share of the Lunsumio market? What are the other regions covered in the report?

Who are the major players in the Lunsumio market?

Major companies operating in the lunsumio market include Roche Holding AG . For further insights on the Lunsumio market, request a sample here.

What are the key trends in the Lunsumio market?

Major trends in the Lunsumio market include FDA Approval Of Lunsumio For Relapsed Or Refractory Follicular Lymphoma Boosts Market Outlook. For further insights on the Lunsumio market, request a sample here.